Charles River Laboratories CRL Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $216M+5.1% | $205.57M-27.7% | $284.48M+17.9% | $241.21M-2.1% | ||
| $719.32M-2.7% | $739.22M-8.3% | $806.1M+5.6% | $763.67M+17.5% | ||
| $299.1M+7.4% | $278.54M-26.7% | $380.26M+48.6% | $255.81M+28.5% | ||
| $1.45B+3.1% | $1.4B-12.8% | $1.61B+11.8% | $1.44B+12.9% | ||
| $1.66B+3.2% | $1.6B-2.2% | $1.64B+11.9% | $1.47B+13.5% | ||
| $2.76B-2.9% | $2.85B-8.0% | $3.1B+8.6% | $2.85B+5.1% | ||
| $340M-53.0% | $723.4M-16.3% | $864.05M-9.5% | $955.28M-10.0% | ||
| $7.14B-5.2% | $7.53B-8.1% | $8.2B+7.8% | $7.6B+8.2% | ||
| $148.8M+6.0% | $140.34M-16.9% | $168.94M-18.0% | $205.92M+3.9% | ||
| $210.42M-15.3% | $248.32M+2.7% | $241.82M-8.5% | $264.26M+20.3% | ||
| $166K+7.1% | $155K-95.1% | $3.17M+135% | $1.35M+1,234% | ||
| $1.12B+12.7% | $994.1M-5.8% | $1.06B-3.3% | $1.09B+5.7% | ||
| $2.14B-4.6% | $2.24B-15.4% | $2.65B-2.2% | $2.71B+1.7% | ||
| $30M-99.3% | $4.02B-11.4% | $4.54B-0.9% | $4.58B+3.3% | ||
| 120M+23,383% | 511K-0.4% | 513K+0.8% | 509K+0.8% | ||
| $1.39B-23.4% | $1.81B-4.0% | $1.89B+31.7% | $1.43B+46.1% | ||
| $3.16B-8.6% | $3.46B-3.8% | $3.6B+20.9% | $2.98B+17.4% | ||
| $7.14B-5.2% | $7.53B-8.1% | $8.2B+7.8% | $7.6B+8.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Charles River Laboratories's total assets?
- Charles River Laboratories (CRL) holds $7.7B in total assets, up 1.9% year over year.
- How much debt does Charles River Laboratories have?
- Charles River Laboratories carries $3.1B in total debt against $2.9B of shareholders' equity, a debt-to-equity ratio of 1.05.
- How much cash does Charles River Laboratories have?
- Charles River Laboratories holds $198.2M in cash and equivalents.
- Can Charles River Laboratories cover its short-term obligations?
- Its current ratio is 1.36 — current assets exceed current liabilities.
- Where does Charles River Laboratories's balance sheet data come from?
- Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
